$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] Combination therapy of chronic hepatitis C: an important step but not the final goal!

Journal of hepatology : the journal of the European Association for the Study of the Liver, v.29 no.6, 1998년, pp.1010 - 1014  

Wedemeyer, H. (aDepartment of Gastroenterology and Hepatology, Medizinische Hochschule Hannover,, Hannover, Germany) ,  Caselmann, W.H. ,  Manns, M.P.

초록이 없습니다.

참고문헌 (52)

  1. N Engl J Med Hoofnagle 336 347 1997 10.1056/NEJM199701303360507 The treatment of chronic viral hepatitis 

  2. Hepatology Lindsay 26 71S 1997 10.1002/hep.510260713 Therapy of hepatitis C: overview 

  3. Science Sidwell 177 705 1972 10.1126/science.177.4050.705 Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl- 1,2,4-triazole-3-carboxamide 

  4. Pediatr Pulmonol Edell 25 154 1998 10.1002/(SICI)1099-0496(199803)25:3<154::AID-PPUL4>3.0.CO;2-M Reduced long-term respiratory morbidity after treatment of respiratory syncytial virus bronchiolitis with ribavirin in previously healthy infants: a preliminary report 

  5. Rev Infect Dis Patterson 12 1332 1990 10.1093/clinids/12.6.1139 Molecular action of ribavirin 

  6. J Clin Invest Heagy 87 1916 1991 10.1172/JCI115217 Inhibition of immune functions by antiviral drugs 

  7. Transplant Proc Jolley 20 703 1988 Longterm skin allograft survival by combined therapy with suboptimal dose of cyclosporine and ribavirin 

  8. Ann N Y Acad Sci Sidwell 284 239 1977 10.1111/j.1749-6632.1977.tb21956.x Effect of ribavirin on viral hepatitis in laboratory animals 

  9. Science Vogt 235 1376 1987 10.1126/science.2435003 Ribavirin antagonizes the effect of azido-thymidine on HIV replication 

  10. J Immunol Ning 160 3487 1998 10.4049/jimmunol.160.7.3487 Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fg12 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response 

  11. Annu Rev Immunol Chisari 13 29 1995 10.1146/annurev.iy.13.040195.000333 Hepatitis B virus immunopathogenesis 

  12. Curr Opin Immunol Modlin 5 511 1993 10.1016/0952-7915(93)90031-M Type 2 cytokines and negative immune regulation in human infections 

  13. Gastroenterology Botarelli 104 580 1993 10.1016/0016-5085(93)90430-K T-lymphocyte response to hepatitis C virus in different clinical courses of infection 

  14. J Immunol Woitas 159 1012 1997 10.4049/jimmunol.159.2.1012 CD30 induction and cytokine profiles in hepatitis C virus core-specific peripheral blood T lymphocytes 

  15. Immunol Today Allen 18 387 1997 10.1016/S0167-5699(97)01102-X Th1-Th2: reliable paradigm or dangerous dogma? 

  16. Hepatology Lechmann 24 790 1996 T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus-positive blood donors without viremia 

  17. Hepatology Bodenheimer 26 473 1997 10.1002/hep.510260231 Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: a multicenter trial 

  18. J Hepatol Dusheiko 25 591 1996 10.1016/S0168-8278(96)80225-X Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study 

  19. Ann Intern Med di Bisceglie 123 897 1995 10.7326/0003-4819-123-12-199512150-00001 Ribavirin as therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial 

  20. J Med Virol Koskinas 45 29 1995 10.1002/jmv.1890450106 Effects of ribavirin on intrahepatic and extrahepatic expression of hepatitis C virus in interferon nonresponsive patients 

  21. J Hepatol Camps 19 408 1993 10.1016/S0168-8278(05)80550-1 Ribavirin in the treatment of chronic hepatitis C unresponsive to alfa interferon 

  22. Hepatology di Bisceglie 16 649 1992 10.1002/hep.1840160307 A pilot study of ribavirin therapy for chronic hepatitis C 

  23. Lancet Reichard 337 1058 1991 10.1016/0140-6736(91)91707-2 Ribavirin treatment for chronic hepatitis C 

  24. J Viral Hepat Hoofnagle 3 247 1996 10.1111/j.1365-2893.1996.tb00050.x Prolonged therapy of chronic hepatitis C with ribavirin 

  25. Pediatr Infect Dis J Long 16 1023 1997 10.1097/00006454-199711000-00004 Long term follow-up of children hospitalized with respiratory syncytial virus lower respiratory tract infection and randomly treated with ribavirin or placebo 

  26. J Hepatol di Bisceglie 21 1109 1994 10.1016/S0168-8278(05)80626-9 Increase in hepatic iron stores following prolonged therapy with ribavirin in patients with chronic hepatitis C 

  27. Toxic Substances Journal Levine 13 171 1994 Onset and reversibility of ribavirin-induced testicular toxicity in mice 

  28. J Hepatol Chemello 23 8 1995 The effect of interferon alfa and ribavirin combination therapy in naive patients with chronic hepatitis C 

  29. Scand J Infect Dis Braconier 27 325 1995 10.3109/00365549509032725 Combined alpha-interferon and ribavirin treatment in chronic hepatitis C: a pilot study 

  30. Gastroenterology Lai 111 1307 1996 10.1053/gast.1996.v111.pm8898645 Long-term efficacy of ribavirin plus interferon alfa in the treatment of chronic hepatitis C 

  31. Lancet Reichard 351 83 1998 10.1016/S0140-6736(97)06088-1 Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. The Swedish Study Group 

  32. Hepatology Poynard 28 387A 1998 An international randomized trial of interferon alfa-2B and ribavirin (Intron A/Rebetol) 48 or 24 weeks vs. interferon alfa-2B Intron A 48 weeks, for first line treatment of chronic hepatitis C [abstract] 

  33. Hepatology McHutchison 28 387A 1998 Interferon alfa 2b alone or in combination with ribavirin in naive chronic HCV patients: a US multicentre trial [abstract] 

  34. Gastroenterology Brillanti 107 812 1994 10.1016/0016-5085(94)90131-7 A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C 

  35. J Hepatol Chemello 28 109 1998 10.1016/S0168-8278(98)80628-4 Retreatment of chronic hepatitis C (CHC) with sequential interferon-ribavirin combination therapy [abstract] 

  36. J Med Virol Schvarcz 46 43 1995 10.1002/jmv.1890460110 Combined treatment with interferon alpha-2b and ribavirin for chronic hepatitis C in patients with a previous non-response or non-sustained response to interferon alone 

  37. Hepatology Davis 26 247A 1997 Retreatment of relapse after interferon therapy for chronic hepatitis C: an international randomized controlled trial of interferon plus ribavirin vs interferon alone [abstract] 

  38. J Hepatol Schalm 26 961 1997 10.1016/S0168-8278(97)80103-1 Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C. Meta-analysis of individual patient data from European centers 

  39. J Viral Hepat Bellobuono 4 185 1997 10.1046/j.1365-2893.1997.00142.x Ribavirin and interferon-alpha combination therapy vs interferon-alpha alone in the retreatment of chronic hepatitis C: a randomized clinical trial 

  40. Ital J Gastroenterol Scotto 28 505 1996 Pilot study of a short course of ribavirin and alpha interferon in the treatment of chronic active hepatitis C not responding to alpha-interferon alone 

  41. Z Gastroenterol Wedemeyer 36 819 1998 Re-treatment of chronic hepatitis C with interferon alpha and ribavirin in non-responders to interferon alpha monotherapy - analysis of the own experience and review of the literature 

  42. J Hepatol Brillanti 28 114 1998 10.1016/S0168-8278(98)80649-1 Response to triple antiviral therapy in interferon non-responders with chronic hepatitis C [abstract] 

  43. Hepatology Boker 25 203 1997 10.1053/jhep.1997.v25.pm0008985291 Long-term outcome of hepatitis C virus infection after liver transplantation 

  44. Transplantation Rosen 62 1773 1996 10.1097/00007890-199612270-00015 Graft loss following liver transplantation in patients with chronic hepatitis C 

  45. N Engl J Med Gane 334 815 1996 10.1056/NEJM199603283341302 Long-term outcome of hepatitis C infection after liver transplantation 

  46. Hepatology Shuhart 26 1646 1997 10.1002/hep.510260638 Histological and clinical outcome after liver transplantation for hepatitis C 

  47. Hepatology Bizollon 26 500 1997 10.1002/hep.510260236 Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation 

  48. Hepatology Feray 22 1084 1995 10.1002/hep.1840220411 An open trial of interferon alfa recombinant for hepatitis C after liver transplantation: antiviral effects and risk of rejection 

  49. Hepatology Wright 20 773 1994 10.1002/hep.1840200402 Interferon-alpha therapy for hepatitis C virus infection after liver transplantation 

  50. Intervirology Caselmann 40 394 1997 10.1159/000150571 Synthetic antisense oligodeoxynucleotides as potential drugs against hepatitis C 

  51. Arch Virol Alt 142 589 1997 10.1007/s007050050105 Core specific antisense phosphorothioate oligodeoxynucleotides as potent and specific inhibitors of hepatitis C viral translation 

  52. Hepatology Alt 22 707 1995 Specific inhibition of hepatitis C viral gene expression by antisense phosphorothioate oligodeoxynucleotides 

관련 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로